Merck & Co., Inc. New York Stock Exchange
Open: $92.65 High: $95.72 Low: $92.55 Close: $94.68
Range: 2022-06-27 - 2022-06-28
Market: Open
Merck & Co., Inc. 2000 GALLOPING HILL ROAD
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
  • CEO: Kenneth C. Frazier
  • Employees: 68,000
  • Sector: Healthcare
  • Industry: Drug Manufacturers
Latest Stocks Posts
Card image
Card image
Card image
MRK News
Latest news about the MRK